Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
topical Timolol
DRUG
2 trials
Sponsors
Loyola University
, Queen Mary Hospital, Hong Kong
Conditions
Benign Vascular Periocular Lesions
Paronychia
Phase 3
Efficacy and Safety of Timolol for TKI Induced Paronychia
NCT06140186
Queen Mary Hospital, Hong Kong
Paronychia
Start: 2023-04-01
End: 2024-03-31
Target: 40
Updated: 2023-12-20
Phase 4
Topical Timolol for the Treatment of Benign Vascular Periocular Lesions
Withdrawn
NCT01250457
Loyola University
Benign Vascular Periocular Lesions
Start: 2010-06-30
End: 2012-07-31
Updated: 2012-10-30